Daniel Weintraub
Daniel Weintraub
Unknown affiliation
Verified email at uphs.upenn.edu
Title
Cited by
Cited by
Year
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium
IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ...
Neurology 65 (12), 1863-1872, 2005
48702005
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines
I Litvan, JG Goldman, AI Tröster, BA Schmand, D Weintraub, RC Petersen, ...
Movement disorders 27 (3), 349-356, 2012
15692012
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients
D Weintraub, J Koester, MN Potenza, AD Siderowf, M Stacy, V Voon, ...
Archives of neurology 67 (5), 589-595, 2010
12892010
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
LS Schneider, PN Tariot, KS Dagerman, SM Davis, JK Hsiao, MS Ismail, ...
New England Journal of Medicine 355 (15), 1525-1538, 2006
12202006
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ...
Neurology 89 (1), 88-100, 2017
10512017
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
S Hoops, S Nazem, AD Siderowf, JE Duda, SX Xie, MB Stern, ...
Neurology 73 (21), 1738-1745, 2009
8622009
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
K Seppi, D Weintraub, M Coelho, S Perez‐Lloret, SH Fox, ...
Movement Disorders 26 (S3), S42-S80, 2011
8532011
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis
D Aarsland, K Bronnick, C Williams-Gray, D Weintraub, K Marder, ...
Neurology 75 (12), 1062-1069, 2010
7442010
Association of dopamine agonist use with impulse control disorders in Parkinson disease
D Weintraub, AD Siderowf, MN Potenza, J Goveas, KH Morales, JE Duda, ...
Archives of neurology 63 (7), 969-973, 2006
7222006
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD‐MCI
I Litvan, D Aarsland, CH Adler, JG Goldman, J Kulisevsky, B Mollenhauer, ...
Movement disorders 26 (10), 1814-1824, 2011
6722011
Depression rating scales in Parkinson's disease: critique and recommendations
A Schrag, P Barone, RG Brown, AFG Leentjens, WM McDonald, ...
Movement disorders 22 (8), 1077-1092, 2007
6182007
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
P Barone, W Poewe, S Albrecht, C Debieuvre, D Massey, O Rascol, ...
The Lancet Neurology 9 (6), 573-580, 2010
4982010
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease
D Weintraub, PJ Moberg, JE Duda, IR Katz, MB Stern
Journal of the American Geriatrics Society 52 (5), 784-788, 2004
4482004
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
D Weintraub, S Hoops, JA Shea, KE Lyons, R Pahwa, ...
Movement disorders: official journal of the Movement Disorder Society 24 (10 …, 2009
3742009
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial
AP Porsteinsson, LT Drye, BG Pollock, DP Devanand, C Frangakis, ...
Jama 311 (7), 682-691, 2014
3722014
Montreal cognitive assessment performance in patients with Parkinson's disease with “normal” global cognition according to mini‐mental state examination score
S Nazem, AD Siderowf, JE Duda, T Ten Have, A Colcher, SS Horn, ...
Journal of the American Geriatrics Society 57 (2), 304-308, 2009
3642009
Impulse control disorders in Parkinson disease: a multicenter case–control study
V Voon, M Sohr, AE Lang, MN Potenza, AD Siderowf, J Whetteckey, ...
Annals of neurology 69 (6), 986-996, 2011
3622011
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
RS Turner, RG Thomas, S Craft, CH Van Dyck, J Mintzer, BA Reynolds, ...
Neurology 85 (16), 1383-1391, 2015
3372015
Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment
D Weintraub, CL Comella, S Horn
Am J Manag Care 14 (2 Suppl), S40-S48, 2008
3312008
Cognitive decline in Parkinson disease
D Aarsland, B Creese, M Politis, KR Chaudhuri, D Weintraub, C Ballard
Nature Reviews Neurology 13 (4), 217-231, 2017
3222017
The system can't perform the operation now. Try again later.
Articles 1–20